Rtw Investments, LP Corvus Pharmaceuticals, Inc. Transaction History
Rtw Investments, LP
- $6.13 Billion
- Q4 2024
A detailed history of Rtw Investments, LP transactions in Corvus Pharmaceuticals, Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 2,679,479 shares of CRVS stock, worth $13.3 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,679,479Holding current value
$13.3 Million% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding CRVS
# of Institutions
96Shares Held
39.9MCall Options Held
1.95MPut Options Held
462K-
Orbimed Advisors LLC San Diego, CA6.94MShares$34.5 Million0.98% of portfolio
-
Samlyn Capital, LLC New York, NY6.67MShares$33.1 Million0.56% of portfolio
-
Adams Street Partners LLC Chicago, IL3.28MShares$16.3 Million18.22% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.03MShares$15.1 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$12.2 Million0.0% of portfolio
About Corvus Pharmaceuticals, Inc.
- Ticker CRVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,553,500
- Market Cap $231M
- Description
- Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...